Viruses, Vol. 16, Pages 366: Recent Advances on Targeting Proteases for Antiviral Development

Viruses, Vol. 16, Pages 366: Recent Advances on Targeting Proteases for Antiviral Development Viruses doi: 10.3390/v16030366 Authors: Pedro Henrique Oliveira Borges Sabrina Baptista Ferreira Floriano Paes Silva Viral proteases are an important target for drug development, since they can modulate vital pathways in viral replication, maturation, assembly and cell entry. With the (re)appearance of several new viruses responsible for causing diseases in humans, like the West Nile virus (WNV) and the recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), understanding the mechanisms behind blocking viral protease’s function is pivotal for the development of new antiviral drugs and therapeutical strategies. Apart from directly inhibiting the target protease, usually by targeting its active site, several new pathways have been explored to impair its activity, such as inducing protein aggregation, targeting allosteric sites or by inducing protein degradation by cellular proteasomes, which can be extremely valuable when considering the emerging drug-resistant strains. In this review, we aim to discuss the recent advances on a broad range of viral proteases inhibitors, therapies and molecular approaches for protein inactivation or degradation, giving an insight on different possible strategies against this important class of antiviral target.
Source: Viruses - Category: Virology Authors: Tags: Review Source Type: research